Overseas Regulatory Announcement-Announcement in Connection with the Drugs of a Wholly-owned Subsidiary Passing the Generic Drugs Consistency Evaluation

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information

Overseas Regulatory Announcement -Announcement of Obtaining FDA Registration Approval Letter for Sevelamer Carbonate (Active Pharmaceutical Ingredients)(1)

Reply Slip for the Second Extraordinary General Meeting for the Year 2024

Proxy Form for the Second Extraordinary General Meeting for the Year 2024

Notice of Extraordinary General Meeting

(1) Continuing Connected Transactions; And(2) Notice of Extraordinary General Meeting

Overseas Regulatory Announcement-Announcement on Febuxostat Tablets Having Obtained the Drug Registration Certificate